Financière de Tubize S.A.
TUB
Κατάταξη σε μετοχές
#2125
Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a... Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a global biopharmaceutical firm, primarily through its investment in UCB. The company is dedicated to discovering and advancing innovative medicines and solutions focused on neurological and immunological disorders. Its current commercial offerings include Cimzia, an established treatment for a range of inflammatory conditions such as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis. For partial-onset seizures in epilepsy, it provides Briviact, Vimpat, and Keppra, alongside Nayzilam, a nasal spray. Neupro addresses Parkinson's disease and restless legs syndrome. Additionally, the portfolio features Evenity, an injectable therapy for osteoporosis, and Bimzelx, used to manage moderate to severe plaque psoriasis. The company's development pipeline highlights several promising candidates: Staccato, aimed at stereotypical prolonged seizures; Bepranemab for Alzheimer's disease; and UCB0599 for Parkinson's disease. Other therapies under investigation include bimekizumab, which targets psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab, for conditions like myasthenia gravis, immune thrombocytopenia, myelin oligodendrocyte glycoprotein antibody disease, and autoimmune encephalitis; and dapirolizumab pegol, intended for systemic lupus erythematosus.
Τιμή μετοχής
$217.90
Τελευταίος συγχρονισμός: 2026-10-20
Κεφαλαιοποίηση
$9.70B
Αλλαγή (1 ημέρα)
5.57%
Αλλαγή (1 έτος)
-19.89%
Χώρα
BE
Εμπόριο Financière de Tubize S.A. (TUB)
Κατηγορία
Healthcare
Ιστορικό μερισμάτων για Financière de Tubize S.A. (TUB)
Η μετοχή Financière de Tubize S.A. (σύμβολο: TUB) κατέβαλε συνολικά 26 μερίσματα.
Το συνολικό ποσό των μερισμάτων (προσαρμοσμένο για διασπάσεις μετοχών) είναι: $13.63
Απόδοση μερίσματος (TTM): 0.0065
Το συνολικό ποσό των μερισμάτων (προσαρμοσμένο για διασπάσεις μετοχών) είναι: $13.63
Απόδοση μερίσματος (TTM): 0.0065
Καταβολές μερισμάτων για Financière de Tubize S.A. (TUB) από 2000 έως 2026
Ετήσιες καταβολές μερισμάτων
| Έτος | Μέρισμα (προσαρμοσμένο για διασπάσεις μετοχών) | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $0.8945 | 0.00% |
| 2025 | $0.8945 | -7.78% |
| 2024 | $0.97 | 12.79% |
| 2023 | $0.86 | 14.67% |
| 2022 | $0.75 | 10.29% |
| 2021 | $0.68 | 9.68% |
| 2020 | $0.62 | 10.71% |
| 2019 | $0.56 | 3.70% |
| 2018 | $0.54 | 3.85% |
| 2017 | $0.52 | 4.00% |
| 2016 | $0.5 | 4.17% |
| 2015 | $0.48 | 0.00% |
| 2014 | $0.48 | 0.00% |
| 2013 | $0.48 | 0.00% |
| 2012 | $0.48 | 0.00% |
| 2011 | $0.48 | 0.00% |
| 2010 | $0.48 | 0.00% |
| 2009 | $0.48 | 1.42% |
| 2008 | $0.4733 | 2.16% |
| 2007 | $0.4633 | 2.21% |
| 2006 | $0.4533 | 3.02% |
| 2005 | $0.44 | 6.46% |
| 2004 | $0.4133 | 8.76% |
| 2003 | $0.38 | 21.29% |
| 2002 | $0.3133 | 23.69% |
| 2001 | $0.2533 | 35.67% |
| 2000 | $0.1867 | 0.00% |
Λίστα όλων των καταβολών μερισμάτων
| Έτος | Μέρισμα | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $0.8945 | 0.00% |
| 2025 | $0.8945 | -7.78% |
| 2024 | $0.97 | 12.79% |
| 2023 | $0.86 | 14.67% |
| 2022 | $0.75 | 10.29% |
| 2021 | $0.68 | 9.68% |
| 2020 | $0.62 | 10.71% |
| 2019 | $0.56 | 3.70% |
| 2018 | $0.54 | 3.85% |
| 2017 | $0.52 | 4.00% |
| 2016 | $0.5 | 4.17% |
| 2015 | $0.48 | 0.00% |
| 2014 | $0.48 | 0.00% |
| 2013 | $0.48 | 0.00% |
| 2012 | $0.48 | 0.00% |
| 2011 | $0.48 | 0.00% |
| 2010 | $0.48 | 0.00% |
| 2009 | $0.48 | 1.42% |
| 2008 | $0.4733 | 2.16% |
| 2007 | $0.4633 | 2.21% |
| 2006 | $0.4533 | 3.02% |
| 2005 | $0.44 | -46.78% |
| 2004 | $0.8267 | 8.78% |
| 2003 | $0.76 | 21.27% |
| 2002 | $0.6267 | 23.68% |
| 2001 | $0.5067 | 35.74% |
| 2000 | $0.3733 | 0.00% |
Καταβολές μερισμάτων για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Αριθμός καταβολών μερισμάτων | Χώρα |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 64.00% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
